Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients

Camilla Vassallo, Andrea Carugno, Federica Derlino, Olga Ciocca, Valeria Brazzelli, Giovanni Borroni

Research output: Contribution to journalArticle

Abstract

Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.

Original languageEnglish
Pages (from-to)E28-E34
JournalCutis
Volume95
Issue number5
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients'. Together they form a unique fingerprint.

  • Cite this